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B. PENCAPAIAN PROJEK: 
(Sila tandakan [/] pada kotak yang bersesuaian dan terangkan secara ringkas di dalam 
ruang di bawah ini. Sekiranya perlu, sila gunakan kertas yang berasingan) 
o Penemuan asli/peningkatan pengetahuan 
Dapat mengenal pasti tahap pengetahuan, sikap dan amalan pesakit diabetes 
terhadap puasa Ramadan. Pengetahuan pesakit adalah rendah mengenai tanda-
tanda hipoglisemia, amalan yang betul semasa berpuasa dan masaalah yang 
mungkin dihadapi jika mereka berpuasa Ramadan. Pada amnya sikap pesakit 
terhadap puasa Ramadan ada lah positif. Pesakit diabetes di Kubang Kerian masih 
mengambil makanan manis semasa berbuka dan kebanyakkannya tidak 
mengamalkan makan lewat malam didalam bulan puasa. 
Berpuasa Ramadan dikalangan pesakit diabetes di Kubang Kerian tidak memberi 
kesan signifikan kepada berat jisim tubuh, tekanan darah, tahap glukos darah, dan 
profil lipid. Terdapat peningkatan yang signifikan terhadap kawalan diabetes 
berdasarkan serum fruktosamin dan peningkatan signifikan dalam osmolaliti urin. 
Pada kesimpulannya, manfaat puasa Ramadan dapat dicapai bukan hanya melalui 
peningkatan pengetahuan tetapi Juga mem r ukan (-<awaianP,eli}i~l<it_i,syc(\r~ 
keselu ru han dari awal. 
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Topic: The impact of Ramadan fasting on metabolic control and biochemical profiles of 
type 2 diabetic patients in Kubang Kerian, Kelantan. 
Introduction: 
Malaysia is an Islamic country with majority of the population is Muslim. Every year in 
Ramadan, the ninth month of Muslim calendar, a Muslim is required to fast everyday 
from the beginning of dawn until sunset. The average duration of fasting in Malaysia is 
13.5 hours and during this period, a person is required to abstain from any oral intake 
including medications. Islam recommends that fasting Muslims eat a meal before dawn, 
called "sahur". Individuals are exempt from Ramadan fasting if they are suffering from 
an illness that could be adversely affected by fasting. They are allowed to restr.ain from 
fasting for one day to a1130 days, depending on the condition of their illness. People 
diagnosed with diabetes fall into this category and may be exempted from the fasting 
requirement. 
Earlier commentaries on the effect of fasting diabetics were mostly letters to editors 
reporting care reports and experience (Barber et al, 1979; Davidson, 1979; Aslam and 
Wilson, 1989). Barber et al (1979) reported half of the interviewed ·patients practice 
Ramadan fasting. The other half claimed exemption on medical grounds but insulin 
therapy is not an obvious reason. The insulin-treated patients noticed less glycosuria. 
They also did not notice any significant increased in hospital admission among those 
patients who choose to fast. 
In 1990, a local study by Mafauzy et al, shows significant difference between the means 
of body weight, serum fructosamine, total calorie intake, total carbohydrate intake and 
percentage of simple carbohydrate intake before and during Ramadan fasting. The 
significant fall in the serum fructosamine level implied that the overall glycemic control 
was significantly better during the fasting month than before. None of the patient had 
symptoms to suggest worsening of glycemic control. This study concluded that for non-
insulin dependent diabetic patients, Ramadan fasting is possible and related to an 
improvement in the diabetic control. 
Rasheed (1992), in his overview on the fast of Ramadan, quoted two studies showing 
very little problems encountered by diabetics in Ramadan. Omar and Motala, 1997; 
recommended all diabetics to be evaluated before the month of Ramadan to assess their 
physical well being, metabolic control, and ability to keep fast. They added that a Muslim 
diabetic should be educated about special problems that may occur during fasting, as well 
as any therapeutic adjustments that may become necessary. Laajam, 1990, reported a 
study on overweight non-insulin diabetic patients, found no significant change in body 
weight, blood glucose 
Study Impact 
At local level, there is no information on what proportion of our diabetic patients that 
continue to fast, and what is their level of knowledge that they have for them to practice 
Ramadan fasting safely. We also lack of information on how they carry on with 
Ramadan fasting in terms of adjustment on drug regimen and alteration in dietary intake. 
Currently, there is no specific health education program for fasting diabetic. 
There is limited information on the impact of Ramadan fasting on biochemical profiles of 
type 2 diabetic patients. As discussed above, studies had shown that there is an 
improvement in diabetic control and body weight during Ramadan if they follow the 
prescribed diet. Information on these issues, as well as the impact of the one-month 
fasting in diabetics is essential to guide patients and medical professional regarding their 
safety and benefits of this practice. This study hopes to provide important informations 
for health care providers in educating and planning the management of diabetic patient 
during fasting month of Ramadan. 
Objective 
General Objective: To study the impact of Ramadan fasting on metabolic control 
and biochemical profile in Type 2 Diabetes Mellitus. 
Specific Objectives: 
1. To identify the knowledge of, attitude towards and practice of type 2 diabetics in 
relation to Ramadan fasting. 
2. To determine the effect of Ramadan fasting on Body Mass Index (BMI) according 
to gender. 
3. To determine the effect of Ramadan fasting on blood pressure according to 
hypertension status (hypertensive and unknown hypertensive) and BMI categories 
(ideal BMI and overweight). 
4. To determine the effect of Ramadan fasting on fasting blood glucose (FBG). 
5. To determine the effect of Ramadan fasting on serum fructosamine level 
according to BMI categories (ideal BMI and overweight). 
6. To determine the effect of Ramadan fasting on urine osmolality according to 
gender. 
7. To determine the effect of Ramadan fasting on lipid profile according to BMI 
categories (ideal BMI and overweight). 
8. To determine the effect of Ramadan fasting on blood urea, serum creatinine and 
uric acid. 
Methodology 
This study was divided into two parts. Part 1 is the Know ledge, Attitude and Practice 
(K.AP) study and part 2 is the study on the effect of Ramadan fasting on BMI, blood 
pressure, glycemic control and hydration status. 
KAP study was a cross sectional study done on type 2 diabetic patients attending Diabetic 
Medical Clinic and Family Medicine Clinic Hospital Universiti Sains Malaysia in 
November to December 2001. The sample size was calculated using single proportion 
formua based on pilot study done at Klinik Kesihatan Bandar Kuala Krai. The calculated 
sample size was 227 subjects. Data collection was done using a validated questionnaire 
set. The study criteria was: 
Inclusion criteria 
1. Muslim patients. 
11. Confinned cases of type 2 diabetes mellitus based on the World Health Organization 
(WHO) 1998 criteria (Alberti and Zimmet, 1998). The criteria is fasting plasma 
glucose more or equal to 7.0 mmol/1 and 2 hours glucose reading of more or equal to 
11.1 mmol/1 or if they are reported as currently using an oral hypoglycemic agent. 
111. Diabetic patients on oral hypoglycemic agents. 
Exclusion criteria 
1. Patients on diet therapy alone or insulin therapy. 
11• Newly diagnosed diabetic patients who are practicing Ramadan fasting for the first 
time since being diagnosed. 
243 type 2 diabetic patients on oral medication had been interviewed. The outcome 
measures were the mean score of knowledge subdomain, proportion of patients who had 
right attitude and practice correctly in relation to Ramadan fasting. 
The study of the effect of Ramadan fasting was a prospective study. Sample size was 
calculated with Power and Sample size (PS software) version 1.0.13 for t-test paired 
(dependent) sample size, at 95% confidence interval with power of 80%. Significant 
mean difference of each variable was based on clinical significance and standard 
deviation of difference was based on other diabetic study findings. The biggest calculated 
sample was 29. Considering the drop out of 20% the minimum sample size required was 
35 subjects. 
Inclusion criteria 
1. Muslim patients. 
11 • Confinned cases of type 2 diabetes mellitus based on World Health Organization 
(WHO) 1998 criteria. The criteria is fasting plasma glucose more or equal to 7.0 
mmol/1 and 2 hours glucose reading of more or equal to 11.1 mmol/1 or if they are 
reported as currently use of oral hypoglycemic agent. 
iii. Diabetic patients who were on oral hypoglycemic agents. 
iv. Patient plan to fast the whole month of Ramadan. 
Exclusion criteria 
1. Diabetic patients not willing to fast or advised not to fast by attending physician. 
11. Pregnant diabetic patients. 
111. Patients on diet therapy alone or insulin therapy. 
iv. Newly diagnosed diabetic patients where responds to therapy are yet to established. 
v. Patients known to have renal failure (serum creatinine> 2mg/dl (176 J..Lmol/1) or on 
dialysis. 
vt. Patient known to have underlying renal disease. 
vii. Patients with liver failure due to alcohol abuse, hepatitis and cirrhosis. 
v1n. Patients with left or right ventricular failure or a combination of both. Left 
ventricular failure characterized by symptoms of exertional dyspnea, cough, fatigue, 
orthopnea and paroxysmal nocturnal dyspnea; and has signs of cardiac enlargement, 
rales, gallop rhythm and pulmonary venus congestion. Right ventricular failure 
characterised by elevated venus pressure, hepatomegaly and dependent edema 
(Massie, 1996). 
ix. Patients who had to break the fast for more than 20% of Ramadan period (6 days). 
Data were collected on four time series (Flow Chart attached). 43 patients completed the 
data collection. Data were analysed using Repeated Measure ANOV A and presented as 
changes in mean and time effect. 
Results 
KAP Study 
Relative higher mean score was noted for question on general health, diabetic 
complication and symptoms of hyperglycemia. The mean score was relatively lower for 
questions regarding symptoms of hypoglycemia (1.7±1.26), correct practice during 
fasting (1.9±0.65) and problems that may arise from fasting (1.9±0.72). 
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Figure 1: Mean score of knowledge subdomains 
*gen=general health, comp=complication, hyper-hyperglycemia symptoms, hypo=hypoglycemia 
symptoms, prac=correct practice, prob=problem that may arise. 
Positive attitude was shown by high proportion of responders who agree on their 
responsibility on control of disease (Question 1 and 2). Similarly, positive attitude was 
shown on their willingness and ability to carry out Ramadan fasting and attitude towards 
physical activity (Question 3, 5 and 6). There were still 11.5% of responders who were 
not convinced that fasting could help diabetes control (Table 1 ). 
Table 1: Percentage of respond for attitude questions. 
Q 1. Should know blood glucose level 
Q2. Able to control disease 
Q3. Unable to fast because need to take medications 
Q4. Fasting can help disease control 
Q5. Ability to fast the whole month 
Q6. Unable to do usual daily activity if fasting 
Agree 
98.4 
92.2 
2.1 
84.0 
93.8 
5.8 
Not sure 
0.4 
7.0 
1.2 
11.5 
1.2 
0.8 
Disagree 
1.2 
0.8 
96.7 
4.5 
4.9 
93.4 
Majority of responders discuss medication schedule adjustment with doctor (83.1 %) and 
take pre-dawn meal or sahur (98.8%), however there were still high proportion of 
responders who take sugary food on breaking fast (41.5%), 28.8% sometimes and 29.6o/o 
always. There was high proportion of those who did not take supper (66.2o/o) {Table 2). 
Table 2: Percentage of respond for practice questions 
Question Never & 
Change medication schedule based on doctor 
advice 
Reduced frequency of medication 
Make sure take sahur (pre dawn meal) 
Take sugary food on breaking fast 
Take supper 
Study of the effect of Ramadan fasting 
1. Body Mass Index (BMI) 
seldom 
10.7 
53.5 
0.4 
41.5 
66.2 
Sometimes Often & 
always 
6.2 83.1 
4.5 42.0 
0.8 98.8 
28.8 29.6 
18.1 15.6 
There was a reduction in mean BMI on fourth week of Ramadan but increased again after 
four weeks of Ramadan (Figure 2) 
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Figure 2: Error bars of mean BMI (kg/m2) in 43 subjects by week in relation to Ramadan 
Repeated Measure ANOV A showed no significant difference of mean BMI across the 
time period (F=3.24, p=0.06) after considering the effect of gender in the model. There 
was a significant interaction between time and gender. 
n. Blood Pressure 
The changes in mean systolic BP was not significant across time after considering the 
effect of hypertension (HPT) status and BMI categories in the model (F=0.30,p=0.82). 
There was no significant interaction between time and hypertension status as well as BMI 
categories (Figure 3). 
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Figure 3: Error bars of mean systolic BP (mmHg) in 43 subjects by week in relation to 
Ramadan. 
Mean diastolic BP showed an increase on fourth week of Ramadan but reduced back to 
similar level after four weeks of Ramadan (Figure 4). These changes were not significant 
across time (F=0.36, p=O. 78) after considering the effect of hypertension status and BMI 
categories in the model. There is no significant interaction between time and 
hypertension status as well as BMI categories 
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Figure 4: Error bars of mean diastolic BP (mmHg) in 43 subjects by week in relation to 
Ramadan 
111. Fasting Blood Glucose 
There was a reduction of mean FBG during Ramadan. The mean FBG increased again 
after four weeks of Ramadan. 
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Figure 5: Error bars of mean FBG (mmol/L) in 43 subjects by week in relation to 
Ramadan 
Repeated measure ANOV A found no significant difference of mean FBG across the four 
time series (F=2.00, p=0.12). 
IV. Serum Fructosamine 
All four mean serum fructosamine levels were above 350 J..Lmol/L indicating poor control 
of diabetics (McGhee, 1994) before Ramadan and even worse on fourth week of 
Ramadan and four weeks after Ramadan as shown in Figure 6. 
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Figure 6: Error bars of mean serum fructosamine level (Jlmol/L) in 43 subjects by week 
in relation to Ramadan. 
Repeated Measure ANOV A was done considering the effect of BMI categories in the 
model. The changes in serum fructosamine level were significant across the four time 
series (F=8.996.p<O.Ol). The significant mean difference were between fourth week of 
Ramadan with four weeks and one week before Ramadan. 
v. Urine Osmolality 
All four mean serum fructosamine levels were above 350 Jlmol/L indicating poor control 
of diabetics (McGhee, 1994) before Ramadan and even worse on fourth week of 
Ramadan and four weeks after Ramadan as shown in Figure 7. 
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Figure 7: Error bars of mean serum fructosamine level (Jlmol/L) in 43 subjects by week 
in relation to Ramadan. 
Repeated Measure ANOV A was done considering the effect of BMI categories in the 
model. The changes in serum fructosamine level were significant across the four time 
series (F=8.996.p<O.Ol). The significant mean difference were between fourth week of 
Ramadan with four weeks and one week before Ramadan. 
v1. Blood Urea 
There was no significant changes in mean blood urea level (F=0.897, p=0.445) after 
considering the effect of hypertension, ACE inhitor treatment, gender and illness 
duration. 
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Figure 8: Error bars of mean urea (mmol/L) in 43 subjects by week in relation to 
Ramadan. 
vn. Serum creatinine 
There was no significant changes of serum creatinine level by the time series. 
Figure 9: Error bar of mean serum creatinine (J.tmol/L) by time series. 
vtn. Uric acid 
There was no significant changes in mean uric acid level by time series. 
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Figure 10: Error bars of uric acid levels (J.tmol/L) by time series 
IX. Lipid profiles (Fasting Triglyceride, Cholesterol, High Density Lipoprotein) 
There were no significant changes in mean cholesterol and HDL by time series. However 
there were significant changes in FTG levels {F=2. 764, p=0.045) after considering the 
effect of gender and BMI categories. 
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Figure 11: Error Bars of mean FTG (mmol/L) by time series. 
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Figure 12: Error bars of mean Cholesterol (mmol/L) by time series 
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Figure 13: Error bars of mean HDL (mmol/L) by time series 
Discussion 
KAPStudy 
This study showed higher mean score of knowledge in term of general health knowledge 
(ideal body weight, physical exercise and dietary control) and diabetic complications on 
renal, heart and eye. This indicates the effect of the health education received. This 
finding was also supported by Norsiah et al. (2002). DCDCP on diabetes health education 
profile in Malaysia reported 77% of patients in East Malaysia received health education 
on healthy eating, 12% on diabetic complication and 13% on hypoglycemia (National 
action plan and strategies, 1998). There was also a high mean score on diabetic 
complication although the DCDCP report showed only a low percentage of health 
education received. This may be due to self-experience and sharing disease experience 
with other patients increase their knowledge. Discussion with attending doctor on blood 
investigation results such as renal function test and referral to Ophthalmologist also play 
a role in enhancing the knowledge of diabetic complications. 
Relatively higher mean score of knowledge for hyperglycemia symptoms may be due to 
the fact that the patients had experienced it and presented with the symptoms on 
diagnosis. The patients also had experienced the symptoms when they were in poor 
controlled state. This is online with the DCDCP report that showed 87.6% of East Coast 
West Malaysia diabetic patients were having FBG of more than 7.8 mmol/L and 92% 
were having HbAtc of more than 7.5% (poor controlled). Knowing to recognize the 
hyperglycemia symptoms can help patients to motivate themselves to avoid 
compensatory eating and taking sugary local foods which were available in abundance 
during Ramadan in this region. A voidance of compensatory eating and abstention from 
high-calorie and highly refined foods had been recommended during Ramadan. fasting in 
order to optimize control (Azizi and Siahkolah, 1998). 
Knowledge score were noted to be relatively lower on hypoglycemia symptoms 
compared to mean score on hyperglycemia symptoms. Patients may have experienced the 
symptoms but did not aware that it is a warning sign of hypoglycemia. This finding was 
very alarming and indicates the need of more health education, since patients who want 
to carry out Ramadan fasting need to know how to recognized warning signs of 
hypoglycemia. They must know how to recognized this condition in order to decide to 
break the fast earlier and thus, prevent further complication and problems (Shahid, 2001 ). 
Knowledge on dietary practice during Ramadan was also relatively poor. Many study 
subjects (81. 9%) answered that they must take heavy meal with rice or bread during pre-
dawn meal or sahur. There were also 18.9% of the study subjects noted that they must 
take sugary food on breaking fast to compensate the fasting glucose level. This finding 
were noted despite good knowledge on the importance of dietary control, which suggest 
that current knowledge was not adequate for the patients to practice Ramadan fasting 
appropriate} y. 
In term of Ramadan fasting helps to control diabetes, there were still 16.0o/o who did not 
know this fact. Previous studies had shown that fasting Ramadan associated with 
improvement in diabetic control instead of making it worsen (Mafauzy et a!, 1990; Azizi 
and Siahkolah, 1998 and Laajam, 1990). This fact is important to be highlighted so that 
patients will be more motivated to control their diet and drug intake during Ramadan 
instead of accusing the fasting practice if they want to maintain good disease control. 
Poorly controlled diabetics may lose excessive water because of high blood glucose. 
When the kidneys cannot conserve water the patient will suffer from dehydration and 
more so if the patient continues to fast (Malaysian Diabetes Association, 1993). 
Knowledge about possible risk of dehydration is important for the patients so that they 
will take adequate water during the non-fasting period of the day along with maintaining 
good diabetic control. Only small proportion of study subjects (36.2%) were aware of this 
risk which should alarmed doctors to emphasized on adequate water intake especially in 
the elderly patients and those who are actively working outdoors during the daytime. 
There were quite a high proportion of study subjects (24.7%) who thought that fasting 
could increase the risk of them getting infections. Patients should be educated that 
infection risk is associated with glucose control (Leibovici et al, 1996; Rayfield et al, 
1982) and not directly from fasting practice. This point should be emphasized together 
with the importance of maintaining good diabetic control during the month. 
Majority of study subjects had positive attitude towards their own responsibility to 
control and monitor their disease and their willingness and ability to carry out fasting 
Ramadan. This correlates well to the fact that many of diabetic patients practice Ramadan 
fasting. The positive attitude on disease control and monitoring can be a good start to 
encouraged more patients to do home blood glucose monitoring. DCDCP had reported 
only 0.4% of patients in East Coast West Malaysia who do self-blood glucose monitoring 
(National action plan and strategies, 1998). Self- monitoring of their blood glucose will 
safeguard from serious disturbance of the blood glucose level during the day especially in 
the first week ofRamadan (Malaysian Diabetes Association, 1993). 
Proper adjustment in the dosage of hypoglycemic agents will lower the risk of 
hypoglycemia and hyperglycemia in fasting diabetic patients. Although many study 
subjects discussed with their doctor, there were portions of them who adjust the schedule 
without doctor consultation. Those who reduced their medication frequency are either 
advised by doctor, adjusted for convenience of taking medication during the non-fasting 
period or reduced it when developed hypoglycemic symptoms. Those who did not reduce 
their drug frequency schedule were mainly those who were on twice daily or once daily 
dose of medication. Even though study subjects adjusted medication regime after 
discussing it with their doctor, patients should be encouraged to do home monitoring to 
ensure control of diabetic state. These facts on drug adjustment once again highlighted 
the need of health education on how to recognized hypoglycemic and hyperglycemic 
symptoms. 
Taking pre-dawn meal and supper had been advice to help prevent possible attack of 
hypoglycemia. Many of the study subjects aware of the need of taking pre-dawn meal to 
avoid them break their fast earlier. They also practice pre dawn meal because they were 
taking their morning dose of medication at dawn, which must be taken with meal. 
However only 33.8% of the study subjects practiced taking supper, mainly because they 
were still feeling full and it was not their usual habit. Thus, emphasis on this should be 
made especially for those who take their second dose of drug before going to bed. 
More than half of them still take sugary food on breaking fast. This finding was similar to 
other study in HUSM which reported a significant increased in the intake of refined 
sugars contained in local delicacies among HUSM diabetic patients during Ramadan 
(Mafauzy et al, 1990) and a study in Riyadh which reported tendency to over-eating 
throughout the non- fasting periods among the study participants (Laajam, 1990). This 
inappropriate dietary intake was also online with the knowledge deficits found in proper 
dietary practice during Ramadan as mention above. 
Study of the effect of Ramadan fasting 
1. Body Mass Index (BMI) 
The changes of mean BMI were not significant across time. Although it was reduced 
from one week before Ramadan, the mean BMI increased again after four weeks of 
resuming non-fasting state. This finding was similar to studies in healthy subjects with 
same time interval measurements (Fedail et al., 1982; El Ati et al., 1995; Maislos et al., 
1998). Similarly, a local study by Mafauzy et al. (1990), reported similar reduction in 
body weight of diabetic patients compared to just before and end of Ramadan. Laajam 
(1990) in Riyadh also noted no significant reduction of body weight in overweight 
diabetic patients just before and after Ramadan. The reduction on fourth week of 
Ramadan was probably due to reduction in total daily calorie intake and carbohydrate 
content of food during Ramadan as reported by studies on diet intake both in healthy and 
diabetic subjects (Husain et al., 1987; Mafauzy eta/., 1990; Maislos et al., 1998). Thus, 
once the subject resumed their usual food habit after Ramadan the measurements 
increased again to almost similar level than before Ramadan measurements. 
This finding indicates that the food restriction during Ramadan was only able to produce 
a small reduction over a short duration. Thus, this reduction does not benefit the overall 
diabetic management in controlling body weight specifically, and also in reducing risk of 
developing syndrome X. However, Ramadan can be the first step to motivate patients to 
reduce their weight through behavior modification in diet intake. 
n. Blood Pressure. 
There were no significant changes of mean systolic and diastolic BP across time. The 
changes were small ranging 0.27 to 1.45 mmHg for systolic BP and 0.04 to 1.09 mmHg 
for diastolic BP. The fluctuation reflected a short interval effect of Ramadan fasting on 
BP. It also reflected that dietary and drug changes during Ramadan did not significantly 
affect the BP control or harm the diabetics even if they were also hypertensives. The 
reduced diet intake may also be accompanied by reduced sodium and other electrolyte 
intake, thus reducing of the blood pressure slightly. This is consistent with findings by 
Husain et a!. (1987) where a decrease in sodium urinary excretion during Ramadan is 
likely to be due to reduced electrolyte intake. The slight reduction in systolic BP during 
Ramadan may also be due to the psychological effect of inner peace and tranquility as 
described by Soliman (2002). Hypertensive patients may also benefit from their body 
weight reduction during Ramadan, as even a 5% reduction in weight will result in 
significant lowering of blood pressure (Ministry of Health Malaysia, 1998). 
111. Fasting Blood Glucose CFBG) 
The mean FBG changes across time were not significant. FBG had been found to have 
seasonal and individual variation (Nattrass, 1996; Yudkin and Stratton, 1996). The 
reduction in FBG from one week before to fourth week of Ramadan with mean difference 
of 0.94 mmol/L may be due to the fluctuation of FBG by time and thus reflected glucose 
blood level at the time of blood taking. The FBG samples during the non-Ramadan 
period were taken in the morning after an overnight fast but the Ramadan samples were 
taken in the afternoon to have similar interval of blood taking from the last meal. 
Afternoon samples may be affected by physical activity before the blood taking resulting 
in lower level. The difference in total calorie and carbohydrate intake during Ramadan as 
reported by Mafauzy et al., (1990), also can influence the FBG level. The difference may 
also be due to variations in the amount or type of food consumed, regularities and 
compliance with prescribed medications, and differences in physical activities. This 
finding was similar with local study finding by Mafauzy et al., (1990), as well as study 
finding in overweight patients in Riyadh (Laajam, 1990) which reported non-significant 
change ofFBG just before and at the end of Ramadan. 
· Serum fructosamine IV. 
The high fructosamine levels found in this study illustrate similar status of glycemic 
control among local diabetic patients as reported by DCDCP based on HbA 1 c. DCDCP 
reported 73% of Malaysia diabetic patients and 92% of East Coast West Malaysia 
diabetic patients were having HbA1c of more than 7.5% (National action plan and 
strategies, 1998). Fructosamine levels increased significantly on fourth week of Ramadan 
and did not change significantly after four weeks of Ramadan. This finding differs from 
Mafauzy et al. (1990), which reported a significant decreased in fructosamine levels. This 
difference may be explained by the study method whereby dietician consultation to assess 
dietary intake of the subjects may influence subjects to be more compliance to the 
prescribed diet resulting in better glycemic control. However, review of literatures by 
Azizi and Siahkolah noted no significant change before and during Ramadan fasting. 
Other studies using HbA1c values reported no change or improvement in glycemic 
control during Ramadan (Laajam, 1990; Azizi and Siahkolah, 1998; Soewondo, 2002). 
The variation in these study findings for fructosamine may be also be due to variation in 
the amount or type of food consumed, regularities and compliance with prescribed 
medications, overeating after the fast is broken or differences in physical activities as in 
FBG findings. 
v. Urine osmolality, blood urea and serum creatinine 
The significant increase in the mean urine osmolality during Ramadan was not beyond 
the nonnal limit suggesting that water deprivation during fasting was not sufficient to 
cause dehydration. This reflects the ability of the kidneys to excrete relatively high 
concentrated urine in the daytime and thus, showed that the body adapted adequately to 
water deprivation during the day. It does also indicate that the concentrating ability of the 
kidneys remained unimpaired during Ramadan. The reduction of the mean back to 
similar level after Ramadan further suggests the body adaptive ability and the changes 
were related to amount of fluid intake. 
The non significant changes in blood urea and serum creatinine also indicates good renal 
adaptation ability to the changes in water intake. Thus, Ramadan fasting does not 
sufficient to cause derangement in renal function. The significant change in the urine 
osmolality level across the time was mainly due to the reduced fluid intake during the 
fasting month. Possible cause of dehydration due to over-exertion (Malaysia Diabetes 
Association, 1993) in the study subjects can be excluded since subjects reported no 
strenuous exercise during fasting although they continue their daily routine physical 
activity. Exposure to the hot sun may also predisposed diabetic patients to dehydration 
(Malaysia Diabetes Association, 1993). However, Ramadan month on year 2001 was 
more in the rainy season rather than hot season. 
Diet therapy is an essential tool in diabetic management. The dietary management by 
giving advice and prescribed individual diet plan was stressed on to help control of 
glucose levels in the blood, to achieve satisfactory body weight and to ensure sufficient 
calories for normal activities. Water on the other hand, is not a nutrient and provides no 
calories. It is however, essential as the medium in which all body processes take place. 
Adequate water intake tended to be forgotten in giving advice to diabetic patients, and 
therefore the need for health education program in Ramadan fasting should be 
emphasized. 
v1. Uric acid 
Serum uric acid had been noted to be very labile with day to day and seasonal variation 
(Wallach 2000). The non significant reduction during Ramadan and increased again after 
one month of Ramadan were most likely due to reduced protein intake and high fat diet 
as found by Nomani eta/, 1990. 
vu. Lipid profiles 
The findings correspond to other findings where studies reported different impact of 
Ramadan on lipid profiles as drug regimens, diet and daily activity need to be taken into 
consideration (Azizi and Siahkolah, 1998). Similar finding in cholesterol by Mafauzy et 
a/, 1990 suggested that these changes were due to diet intake related to environment 
factors surrounding the patients. 
Limitations 
The pre-test study to evaluate the KAP questionnaire set was best done during Ramadan 
since it will be used during Ramadan. This was not possible because of time constraint to 
start this study in Ramadan month in order to reduce recall bias particularly questions on 
dietary and drug practice. There was possibly a selection bias of subjects by taking 
patients who attended clinics during the month. Selection of subjects from HUSM 
Diabetes register was tried but most of the patients were reluctant to come during 
Ramadan for various reasons especially those who depended on other family members. 
However, those patients who attended the clinics were given appointment date during 
their last visit before Ramadan or they came to continue medication. The bias may be in 
attitude whereby those who came to the clinics were more motivated with regards to 
fasting Ramadan. The KAP study was unable to describe appropriateness of drug practice 
during Ramadan due to lack of questions specification based on treatment received and 
reason of drug adjustment. 
The study of the effect of Ramadan fasting does not include control group. It was not 
possible to find Muslim diabetics without acute complication who does not practice 
Ramadan fasting in this locality. Taking baseline parameter reading four weeks and one 
week before Ramadan can help illustrating the baseline of the subjects and act as control 
of their own changes in term of time effect. 
The study of the effect of Ramadan fasting was also subjected to selection bias. Those 
who were willing to come on four consecutive visits may be more motivated in terms of 
compliance and disease control. Adjusting the follow-up date according to their 
appointment dates to the specialist clinic, work and personal schedule minimized this bias 
in helping them to come for the visits. Observer bias was handled by appointing only one 
research assistant to take body weight readings and one researcher to take blood pressure 
readings. 
This study does not include dietary information to explain the changes in BMI, FBG and 
fructosamine levels. The dietary history if taken by hospital dietician may influence the 
dietary habit and indirectly the glycemic control of the subjects and thus obscure the 
effect of Ramadan fasting with the usual current practice among patients who does not 
have specific guide on diet adjustment during Ramadan. Blood pressure and FBG 
measurements were also subjected to the regression to the mean effect since these 
parameters were known to fluctuate within an individual. Taking two measurements 
before the intervention can avoid this effect. The second measurement acts as the baseline 
to assess the intervention effect (Yudkin and Stratton, 1996). In this study, even though 
not assigned by investigator, Ramadan fasting can be taken as intervention. Taking 
measurements several time in a day or everyday during Ramadan was not practicable in 
this study and may also not be ethically accepted. Using Repeated Measure ANOV A 
analysis can also handle the regression to mean effect of repeated measurements. 
Conclusion 
Type 2 diabetic management is aimed for glycemic control and preventing further 
complications. This study noted high score of knowledge and attitude as well as diet 
practice. Ramadan fasting was found to have no harmful effect of on BP and does not 
sufficient to cause hypoglycemia and dehydration. Ramadan fasting also does not seem to 
benefit BMI and glycemic control. These findings suggest that safety and benefits of 
Ramadan fasting among type 2 diabetics without acute complication is not dependent on 
KAP on Ramadan fasting per se but depends on the good management of diabetics even 
during the non-Ramadan period. Therefore, the whole diabetes care and pre-Ramadan 
considerations of the monitoring and metabolic control are essential in advising diabetics 
on Ramadan fasting. 
Recommendations 
1. Further studies need to be precise In term of medication schedule, 
adjustment done and reason of the adjustment to identify practice on drug 
adjustment during Ramadan in further detail. 
n. Matched comparative study with non-diabetic subjects of the impact of 
Ramadan fasting in type 2 diabetics on physical and biochemical profiles, 
such as BP, renal and liver function will illustrate the safety of Ramadan 
fasting in diabetic patients. 
nt. Other factors such as dietary habits, food composition, calorie control and 
measurements during each week of Ramadan should be taken into 
consideration in research on diabetics during Ramadan. 
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